📰 Rob Winder News
Page 2 - Rob Winder News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Rob Winder. Real-time updates on events, politics, business and more.
June 1, 2023
Investment will enable pHion to progress its lead program into the clinicTransaction builds on invoX’s initial investment in 2021LONDON--(BUSINESS WIRE)--invoX Pharma Limited (“invoX”), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited (“Sino Biopharm”) (HKEX 1177 HK) with an advancing pipeline...
April 26, 2023
L’AFP est une agence d’information globale, assurant une couverture rapide, complète et vérifiée des événements de l’actualité comme des thèmes qui façonnent notre quotidien. Avec un réseau de journalistes sans égal, déployé sur 151 pays, l'AFP est en outre un leader mondial de l’investigation nu...
March 9, 2023
invoX Pharma Limited ("invoX"), a U.K.-based wholly-owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK) with an advancing pipeline of innovative products, today announces
February 14, 2023
Investegate announcements from PureTech Health PLC, PRTC Plans Ph2a trials w/ LYT-300 in PPD/Anxiety
January 26, 2023
LONDON, Jan. 26, 2023 (GLOBE NEWSWIRE) -- invoX Pharma ("invoX"), a wholly owned subsidiary of Sino Biopharmaceutical Limited ("Sino Biopharm") (HKEX 1177 HK), and F-star Therapeutics, Inc. ("F-star")
December 19, 2022
Investegate announcements from PureTech Health PLC, LYT-300 Shows Proof of Principle in Clinical Trial
December 8, 2022
“This is not one of our more fun projects,” said Tracy Aviary’s conservation director. But the survey helps identify species that are particularly vulnerable to building collisions.
December 1, 2022
A recent report from the University of Utah’s Gardner Policy Institute finds family caregivers report worse physical and mental health than their peers.
September 20, 2022
Rob is a native of Salt Lake City and is happy to be back home and enjoying “one of the best backyards in the world” again.
September 6, 2022
LYT-100 was well-tolerated compared to pirfenidone in a healthy older adult crossover trial, informing dose selection for recently initiated trial in IPF PureTech Health plc (Nasdaq: PRTC, LSE: